Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors

NCT05741242 is registered in ClinicalTrials.gov with Jaime Leandro Foundation for Therapeutic Cancer Vaccines as lead sponsor.

NCT NCT05741242
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05741242 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2, Multi-center, Single Arm Study to Assess the Safety and Efficacy of Neoantigen Synthetic Long Peptide Vaccines in Patients With Local Or Metastatic Solid Tumors
Lead sponsor
Jaime Leandro Foundation for Therapeutic Cancer Vaccines
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
November 30, 2022
Completion date
January 31, 2029
Enrollment
136 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, solid tumor